The top executives of the three drug companies that control 90% of the global insulin market will testify May 10 before the Senate Health Committee on lowering prices of their diabetes drugs, panel Chairman Sen. Bernie Sanders said Friday.
Eli Lilly and Co. expects Medicare health plan to back down from strict coverage limits on new Alzheimer's drugs as more evidence emerges in coming weeks showing that clearing amyloid brain plaques can help patients, a company executive told Reuters.
The U.S. Supreme Court on Wednesday extended until Friday at midnight an administrative stay in an ongoing lower-court fight over the FDA-approved use of the abortion pill mifepristone.
The Supreme Court is deciding whether women will face restrictions in getting a drug used in the most common method of abortion in the United States, while a lawsuit continues.
The U.S. Supreme Court was set on Tuesday to consider a bid by whistleblowers to revive lawsuits accusing pharmacy operators of pocketing millions of taxpayer dollars by knowingly overbilling government health insurance programs.